有症状男性尿道炎中的生殖支原体:大环内酯类药物使用与耐药性增加相关
该研究在有症状尿道炎的男性中检测生殖支原体(MG)及其他性传播感染,并通过测序分析MG对阿奇霉素等大环内酯类和氟喹诺酮类的耐药突变。结果显示MG感染总患病率为19.7%,近90%的MG对两类药物耐药,近期使用大环内酯类药物者耐药率更高。
要点
- MG感染在有症状男性尿道炎中患病率为19.7%(358/1816)。
- 近90%的MG菌株对大环内酯类和氟喹诺酮类耐药。
- 近期(30天内)使用大环内酯类药物者MG耐药率高达96.7%。
核心结论
- MG是有症状男性尿道炎的重要病原,且近90%的MG对氟喹诺酮类药物耐药。
- 近期使用大环内酯类药物与MG大环内酯耐药率增高相关(96.7%,P < .03)。
研究设计与样本
- 研究纳入1816例有症状尿道炎男性患者。
- 通过测序检测MG对大环内酯类和氟喹诺酮类耐药基因,并分析近期抗菌药物使用对MG感染分布的影响。
主要发现
- MG总患病率为19.7%(358/1816)。
- 88.9%(303/341)的MG 23S rRNA基因存在大环内酯耐药突变,89.5%(308/344)的parC和12.4%(42/339)的gyrA基因存在氟喹诺酮耐药突变。
- 约88%(270/308)的MG同时有23S rRNA和parC基因突变,10.4%(32/308)有这三个基因的突变。
- 在入组前30天内自我服用或被处方抗生素的单一MG感染男性比例显著高于MG混合感染男性(P < .0001)。
临床怎么用
- 在男性尿道炎病原学检测中应考虑MG,尤其对经验性使用过抗生素者需警惕大环内酯耐药。
- 治疗MG前应了解近期大环内酯类使用史,并优先进行耐药检测以指导用药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mycoplasma genitalium (MG) causes symptomatic urethritis in men, and can infect alone or together with other sexually transmitted infection (STI) agents. METHODS: The prevalence of MG and other STIs was determined in 1816 men with symptomatic urethritis. Resistance of MG to macrolides and fluoroquinolones was determined by sequencing; the impact of recent antimicrobial usage on the distribution of MG single or mixed infections was determined. RESULTS: Overall, prevalence of MG infection was 19.7% (358/1816). Fifty-four percent (166/307) of MG infections occurred alone in the absence of other STI agents. Men with single MG infection self-administered or were prescribed antibiotics more often in the 30 days prior to enrollment than subjects with urethritis caused by MG coinfection (P < .0001). Higher rates (96.7%) of infection with macrolide resistance in MG were identified in men who had taken macrolides prior to enrollment (P < .03). Overall, 88.9% (303/341) of 23S ribosomal RNA (rRNA) genes contained mutations responsible for macrolide resistance; 89.5% (308/344) of parC and 12.4% (42/339) of gyrA genes had mutations responsible for fluoroquinolone resistance. Approximately 88% (270/308) of MG had combined mutations in 23S rRNA and parC genes; 10.4% (32/308) had mutations in all 3 genes. CONCLUSIONS: MG was the single pathogen identified in 11% of men with symptomatic urethritis. Overall, nearly 90% of MG infections were resistant to macrolides and fluoroquinolones. Men who took macrolides in the 30 days prior to enrollment had higher rates (97%) of macrolide-resistant MG. Resistance was associated with numerous mutations in 23SrRNA, parC, and gyrA genes.
引用
- Li Y, Su X, Le W, et al. Mycoplasma genitalium in Symptomatic Male Urethritis: Macrolide Use Is Associated With Increased Resistance. Clin Infect Dis. 2020. PMID: 30972419. doi:10.1093/cid/ciz294
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。